Literature DB >> 15648194

The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.

Paola Muti1.   

Abstract

Breast cancer is the most common cause of cancer death in women worldwide. Rates vary about fivefold around the world, but they are increasing in regions that until recently had low rates of disease. Despite the numerous uncertainties surrounding the etiology of breast cancer, intensive epidemiological, clinical, and genetic studies have identified a number of biological and social traits as risk factors associated with breast cancer. Principal among them is the evidence of BRCA1 and BRCA2 susceptibility genes, familial history of breast cancer, age, higher socioeconomic status, ionizing radiation, tallness in adult life, alcohol consumption, and a variety of hormone and metabolic factors. Among the hormonal influences, a relevant etiological function has been ascribed to unopposed exposure to elevated levels of estrogens and androgens. In addition, new epidemiologic evidence has indicated that among the metabolic factors, glucose metabolism, hyperinsulinemic insulin resistance, and insulin-like growth factor bioavailability may also play a role in breast cancer. These endocrine and metabolic factors may represent future targets for breast cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15648194     DOI: 10.1007/3-540-26980-0_16

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  9 in total

1.  Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Authors:  Alan A Arslan; Karen L Koenig; Per Lenner; Yelena Afanasyeva; Roy E Shore; Yu Chen; Eva Lundin; Paolo Toniolo; Göran Hallmans; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-27       Impact factor: 4.254

2.  Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Authors:  Alan A Arslan; Roy E Shore; Yelena Afanasyeva; Karen L Koenig; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

3.  Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI.

Authors:  Jeon-Hor Chen; Siwa Chan; Dah-Cherng Yeh; Peter T Fwu; Muqing Lin; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2012-12-05       Impact factor: 2.546

4.  Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle.

Authors:  J H Chen; W P Chen; S Chan; D C Yeh; M Y Su; C E McLaren
Journal:  Ann Oncol       Date:  2013-05-09       Impact factor: 32.976

5.  Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.

Authors:  Catalina Machuca; Criselda Mendoza-Milla; Emilio Córdova; Salvador Mejía; Luis Covarrubias; José Ventura; Alejandro Zentella
Journal:  BMC Cell Biol       Date:  2006-02-21       Impact factor: 4.241

6.  Tamoxifen-associated vasculitis in a breast cancer patient.

Authors:  Myrna Candelaria; Rafael Hurtado-Monroy; Pablo Vargas-Viveros; Silvia Carrillo-Muñnoz; Alfonso Duenas-Gonzalez
Journal:  World J Surg Oncol       Date:  2007-01-23       Impact factor: 2.754

Review 7.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03

8.  Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human.

Authors:  Shi-Shan Deng; Tian-Yong Xing; Hong-Ying Zhou; Ruo-Hong Xiong; You-Guang Lu; Bin Wen; Shang-Qing Liu; Hui-Jun Yang
Journal:  Genomics Proteomics Bioinformatics       Date:  2006-08       Impact factor: 7.691

9.  A novel use of biomarkers in the modeling of cancer activity based on the theory of endobiogeny.

Authors:  Laura J Buehning; Kamyar M Hedayat; Aarti Sachdeva; Shahrokh Golshan; Jean Claude Lapraz
Journal:  Glob Adv Health Med       Date:  2014-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.